Privium Fund Management B.V.
- SEC CIK
- 0001795097
- Latest filing
- Aug 7, 2026
Holdings in Q3 2025
Holdings as of Sep 30, 2025, filed Nov 4, 2025. Long positions only; changes compare share counts with Q2 2025.
- Positions
- 59
- +4 vs. Q2 2025
- Portfolio value
- $556.3M
- +$92.8M (+20.0%) vs. Q2 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TSLATesla, Inc. | Stock | 244,000 | $108.5M | 19.5% | +2,000+0.8% | Added | History |
| SPOTSpotify Technology S.A. | Stock | 95,000 | $66.3M | 11.9% | −19,000−16.7% | Reduced | History |
| SHOPShopify Inc. | Stock | 415,000 | $61.7M | 11.1% | −15,000−3.5% | Reduced | History |
| PLTRPalantir Technologies Inc. | Stock | 200,000 | $36.5M | 6.6% | −150,000−42.9% | Reduced | History |
| AMZNAmazon Com Inc | Stock | 149,000 | $32.7M | 5.9% | 00.0% | Unchanged | History |
| SESea Ltd | SPONSORD ADS | 160,000 | $28.6M | 5.1% | −50,000−23.8% | Reduced | History |
| COINCoinbase Global, Inc. | COM CL A | 79,000 | $26.7M | 4.8% | +9,000+12.9% | Added | History |
| QUREuniQure N.V. | SHS | 386,000 | $22.5M | 4.1% | −61,486−13.7% | Reduced | History |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 473,951 | $16.3M | 2.9% | −138,263−22.6% | Reduced | History |
| IONSIonis Pharmaceuticals Inc | COM | 248,894 | $16.3M | 2.9% | −18,700−7.0% | Reduced | History |
| NVDANVIDIA Corp | Stock | 81,000 | $15.1M | 2.7% | 00.0% | Unchanged | History |
| PRQRProQR Therapeutics N.V. | SHS EURO | 4,998,287 | $10.6M | 1.9% | +7250.0% | Added | History |
| AMDAdvanced Micro Devices Inc | Stock | 60,000 | $9.71M | 1.7% | +60,000 | New | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 289,804 | $8.72M | 1.6% | +36,500+14.4% | Added | History |
| LMNDLemonade, Inc. | Stock | 145,000 | $7.76M | 1.4% | +145,000 | New | History |
| BIIBBiogen Inc. | COM | 51,925 | $7.27M | 1.3% | +31,425+153.3% | Added | History |
| AXSMAxsome Therapeutics, Inc. | COM | 52,732 | $6.40M | 1.2% | 00.0% | Unchanged | History |
| IRENIREN Ltd | ORDINARY SHARES | 130,000 | $6.10M | 1.1% | +130,000 | New | History |
| ARQTArcutis Biotherapeutics, Inc. | COM | 305,972 | $5.77M | 1.0% | −38,500−11.2% | Reduced | History |
| MRKMerck & Co., Inc. | Stock | 64,393 | $5.40M | 1.0% | +5,300+9.0% | Added | History |
| ASTSAST SpaceMobile, Inc. | COM CL A | 110,000 | $5.40M | 1.0% | +110,000 | New | History |
| ZLABZai Lab Ltd | ADR | 132,189 | $4.48M | 0.8% | 00.0% | Unchanged | History |
| URGNUroGen Pharma Ltd. | COM | 196,622 | $3.92M | 0.7% | +89,000+82.7% | Added | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 8,300 | $3.25M | 0.6% | 00.0% | Unchanged | History |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | 40,000 | $2.59M | 0.5% | −4,700−10.5% | Reduced | History |
| ABVXAbivax S.A. | SPONSORED ADS | 30,412 | $2.58M | 0.5% | +30,412 | New | History |
| Avidity Biosciences, Inc.05370A108 | COM | 53,000 | $2.31M | 0.4% | +7,000+15.2% | Added | – |
| HIMSHims & Hers Health, Inc. | Stock | 40,000 | $2.27M | 0.4% | +18,000+81.8% | Added | History |
| KRYSKrystal Biotech, Inc. | COM | 12,170 | $2.15M | 0.4% | +2,850+30.6% | Added | History |
| ABEVAmbev S.A. | SPONSORED ADR | 897,134 | $2.00M | 0.4% | +101,348+12.7% | Added | History |
| ROIVRoivant Sciences Ltd. | SHS | 126,923 | $1.92M | 0.3% | 00.0% | Unchanged | History |
| BNTXBioNTech SE | SPONSORED ADS | 19,000 | $1.87M | 0.3% | +8,013+72.9% | Added | History |
| FDMT4D Molecular Therapeutics, Inc. | COM | 197,458 | $1.72M | 0.3% | 00.0% | Unchanged | History |
| ACADAcadia Pharmaceuticals Inc | COM | 70,400 | $1.50M | 0.3% | −78,000−52.6% | Reduced | History |
| BEAMBeam Therapeutics Inc. | COM | 61,000 | $1.48M | 0.3% | +61,000 | New | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 432,760 | $1.41M | 0.3% | 00.0% | Unchanged | History |
| MGTXMeiraGTx Holdings plc | COM | 163,000 | $1.34M | 0.2% | 00.0% | Unchanged | History |
| LXEOLexeo Therapeutics, Inc. | COM | 192,356 | $1.28M | 0.2% | +14,000+7.8% | Added | History |
| WVEWave Life Sciences, Inc. | SHS | 170,000 | $1.24M | 0.2% | +34,450+25.4% | Added | History |
| MRNAModerna, Inc. | Stock | 47,000 | $1.21M | 0.2% | −56,433−54.6% | Reduced | History |
| SASeabridge Gold Inc | COM | 48,474 | $1.17M | 0.2% | +4,400+10.0% | Added | History |
| PFEPfizer Inc | Stock | 37,750 | $961.9K | 0.2% | +721+1.9% | Added | History |
| ALXOAlx Oncology Holdings Inc | COM | 509,059 | $931.6K | 0.2% | 00.0% | Unchanged | History |
| VZLAVizsla Silver Corp. | COM NEW | 204,654 | $884.1K | 0.2% | −46,136−18.4% | Reduced | History |
| NOVNOV Inc. | COM | 63,876 | $846.4K | 0.2% | 00.0% | Unchanged | History |
| PAASPan American Silver Corp | Stock | 18,531 | $717.7K | 0.1% | −11,216−37.7% | Reduced | History |
| Sprott FDS Tr85208P303 | URANIUM MINERS E | 11,448 | $691.8K | 0.1% | −4,830−29.7% | Reduced | – |
| SLBSLB Limited | Stock | 19,697 | $677.0K | 0.1% | +19,697 | New | History |
| RXRXRecursion Pharmaceuticals, Inc. | CL A | 119,000 | $580.7K | 0.1% | 00.0% | Unchanged | History |
| SDSandridge Energy Inc | COM NEW | 50,392 | $568.4K | 0.1% | +13,370+36.1% | Added | History |
| AUTLAutolus Therapeutics plc | SPON ADS | 308,837 | $503.4K | 0.1% | +14,695+5.0% | Added | History |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 134,900 | $441.1K | 0.1% | 00.0% | Unchanged | History |
| FATEFate Therapeutics Inc | COM | 333,219 | $419.9K | 0.1% | +222,129+200.0% | Added | History |
| VALValaris Ltd | CL A | 8,315 | $405.5K | 0.1% | −5,488−39.8% | Reduced | History |
| NENoble Corp plc | ORD SHS A | 14,287 | $404.0K | 0.1% | 00.0% | Unchanged | History |
| RIGTransocean Ltd. | REGISTERED SHS | 102,000 | $318.2K | 0.1% | +102,000 | New | History |
| SBSWSibanye Stillwater Ltd | SPONSORED ADR | 26,232 | $294.8K | 0.1% | −7,808−22.9% | Reduced | History |
| TDWTidewater Inc | COM | 5,483 | $292.4K | 0.1% | +133+2.5% | Added | History |
| VYGRVoyager Therapeutics, Inc. | COM | 45,000 | $210.2K | <0.1% | +19,759+78.3% | Added | History |
Sold out since Q2 2025 (4)
Positions held at the end of Q2 2025 that are gone from this filing.
| Security | Class | Shares in Q2 2025 | Value in Q2 2025 | % of portfolio in Q2 2025 | History |
|---|---|---|---|---|---|
| CVNACarvana Co. | CL A | 5,000 | $1.68M | 0.4% | History |
| SRPTSarepta Therapeutics, Inc. | COM | 39,400 | $697.8K | 0.2% | History |
| Emx Rty Corp26873J107 | COM | 216,968 | $544.6K | 0.1% | – |
| DYNDyne Therapeutics, Inc. | COM | 27,566 | $239.3K | 0.1% | History |